Posts Tagged ‘Aridhia’

Aridhia cements success with new office in Scotland’s precision medicine hub

Wednesday, December 7th, 2016

AridhiaLogo

 

Today clinical and translational informatics company, Aridhia, celebrate the opening of its new office in the Queen Elizabeth University Hospital, the largest acute hospital in Western Europe.

Located in the University of Glasgow’s Clinical Innovation Zone in the hospital’s Teaching and Learning Centre alongside Stratified Medicine Scotland Innovation Centre (SMS-IC), Aridhia’s new office is home to an expanding team with a focus on data and analytics innovation in biomedical research and precision medicine. (more…)

Aridhia broadens European appeal with new RSRCH-Health service in Netherlands

Thursday, December 1st, 2016

AridhiaLogo

Scottish clinical and translational informatics company Aridhia, Netherlands-based ICT service provider Vancis, and clinical datasets experts MGRID are today announcing the expansion of their existing partnership with the launch of a new research platform service, RSRCH-Health, into the Netherlands.

The initiative will be introduced at the Health-RI conference on December 1st in Amersfoort, Netherlands to an audience of researchers, academics and clinicians who are being encouraged to work together to enable ground-breaking biomedical research. (more…)

University of Glasgow researchers make an impact in 60 seconds to win science storytelling award

Friday, November 20th, 2015

aridhia

 

Edinburgh based informatics company, Aridhia, today announced the winners of its first Impact in Sixty Seconds competition, in partnership with The University of Glasgow College of Medical, Veterinary and Life Sciences (MVLS) and Glasgow City of Science.

Early-career researchers from MVLS were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research. This was an opportunity for students to present their work in simple terms that anyone could understand, even the general public.

The award recognises the importance of engagement and communication between innovative collaborations in the field of medical science. It promotes the pivotal role of open innovation in preparing UK researchers to face future challenges when undertaking collaborative research.
(more…)

Aridhia Announces Northern Ireland Based Alzheimer’s Research Collaboration to Benefit from AnalytiXagility Workspace

Tuesday, November 3rd, 2015

aridhia

 

Aridhia, the Edinburgh based clinical informatics company, announced today that their AnalytiXagility data platform has been chosen to underpin a three year research programme that was awarded Innovate UK funding via the Neurodegenerative Diseases: Business Models and Big Data competition, following a joint bid by three of Northern Ireland’s leading organisations.

The resulting Moneta Research project – led by Asystec Data Solutions, the University of Ulster and the Clinical Translational Research and Innovation Centre (C-TRIC) – will use the funding to support their research into identifying people most likely to develop Alzheimer’s.
(more…)

Aridhia and Vancis join forces to bring combined cloud collaboration services to Netherlands medical research sector

Saturday, August 1st, 2015

aridhia

 

Aridhia, the pioneering Scottish clinical and translational informatics company, has announced a partnership in the Netherlands which it says will unite two of Europe’s leading providers of services to healthcare organisations, and expand Aridhia’s service to the country.

Following the success of Aridhia’s Research as a Service and translational informatics platform in the Horizon 2020 EU Research and Innovation programme, and other European healthcare projects, Aridhia’s collaboration with Vancis is seen as a strong endorsement of the strength of the Netherlands’ research sector.
(more…)

Aridhia announces revolutionary mini-app technology to accelerate clinical application development following RStudio collaboration

Friday, July 10th, 2015

aridhia

 

Aridhia enhances AnalytiXagility data innovation platform with rapid prototyping technology from the leading “R” language tools provider RStudio to accelerate the translation of precision medicine and biomedical research into clinical practice.

Aridhia, the pioneering clinical and translational informatics company, today announced a revolutionary “mini-app” rapid development solution specifically for clinical applications. The solution integrates the RStudio Shiny web application framework and Shiny Server Pro secure, performant application deployment platform to enhance AnalytiXagility’s collaborative workspaces.

(more…)

Aridhia’s Data Science Platform Used in €6 Million EU Project

Wednesday, June 17th, 2015

aridhia

 

Aridhia’s data science platform AnalytiXagility has been chosen to underpin a €6 million oral healthcare innovation project funded by the EU’s Horizon 2020 programme and the funding win demonstrates huge confidence in Aridhia’s data analytics capability.

During the four-year project, known as ADVOCATE, the Edinburgh-based company will work with 10 partners spanning academia, healthcare and industry across six EU states, to deliver an innovative, evidence-based oral healthcare model which optimises oral health and wellbeing.

(more…)

Aridhia’s Chris Roche takes over as CEO

Tuesday, April 28th, 2015

aridhia

 

Aridhia’s Board of Directors has announced the appointment of Chris Roche as Chief Executive Officer (CEO), succeeding co-founder David Sibbald, who takes up the role of Executive Chairman at the pioneering health informatics company.

“During this critical time of growth, there is no better person to lead Aridhia than Chris Roche,” says David Sibbald. “Chris is a proven leader with a deep understanding of data science, business vision and the ability to bring people together. His ability to rapidly scale data businesses and corporate experience is precisely what Aridhia needs as we enter our next chapter of innovation and growth.”

Roche joined the company in 2014 as Chief Commercial Officer (CCO) and over the last 12 months has brought a new commercial focus to the company as Aridhia transformed to a SaaS based business model.

(more…)

Aridhia sets its sights on US market with Craneware partnership

Wednesday, March 11th, 2015

aridhia

 

Aridhia Informatics, the Edinburgh-based health informatics company, has announced a strategic partnership with fellow Scottish health tech pioneer Craneware as it targets the US market for the first time.

The partnership will enable Aridhia, which has healthcare clients throughout the UK, Australia and Kuwait, to offer its core services – collaborative analytics platform, data science services and app development capability – to Craneware’s extensive US client base. It represents a major opportunity for both parties to work together to help US healthcare organisations benefit from the acceleration and commercialisation of informatics solutions that focus on patient outcomes. A growing number of medical insurers are moving away from fee-for-service towards performance-based reimbursement and this is driving the requirement for informatics solutions.

(more…)

Aridhia secures place on G-Cloud 6 framework

Tuesday, February 3rd, 2015

aridhia

 

World-leading health informatics company Aridhia has successfully been awarded a place on the UK Government’s G-Cloud procurement portal for a second term, making its analytics platform, data science services, and app development capability widely accessible to healthcare providers and research collaborations.

The G-Cloud framework enables healthcare organisations such as NHS Trusts and Clinical Commissioning Groups (CCGs) to procure cloud-based Software as a Service (SaaS) systems and applications on a monthly subscription basis. This enables users to access Aridhia’s platform – AnalytiXagility – without the need for costly infrastructure investment and lengthy installation time.

(more…)

Aridhia Appointed to UK Government’s G-Cloud Framework

Tuesday, June 3rd, 2014

The latest in collaborative analytical capability now available on-demand to Government and Healthcare Organisations enabling data-driven healthcare

Health and biomedical informatics company, Aridhia, has been accepted onto the UK government’s G-Cloud Framework. This means that AnalytiXagility, the advanced analytics platform for collaborative data science developed by Aridhia, is now available for the first time through CloudStore’s pay-as-you-go model.

The AnalytiXagility platform delivers on demand collaborative, secure, analytical workspaces allowing multi-disciplinary teams to connect with, load and analyse data sets of all sizes. AnalytiXagility also offers specific sector capability such as the DiabetesDataProfiler within the Healthcare sector, in addition to its core collaborative, analytic and security capability.

Data-driven healthcare will enable integrated chronic disease management ultimately improving patient outcomes through effective, efficient service delivery and, in time, transforming healthcare delivery.
(more…)

Aridhia Appoints Former EMC Director Chris Roche

Wednesday, May 14th, 2014

Aridhia announced today the appointment of Chris Roche to a newly created post on its executive team of Chief Commercial Officer.

Roche joins Aridhia from global IT company – EMC – where he worked for 14 years, playing a key role in business transformation, as it grew from 5,000 to 60,000 people world-wide.

Roche combines a background in computing, specialising in artificial intelligence, with a strong commercial drive and focus. He will now apply his experience of bringing disruptive technology into new sectors, taking Aridhia and its AnalytiXagility platform to market.

Roche comments: “I have worked with disruptive technologies for over a decade and the AnlaytiXagility platform has fantastic potential to transform healthcare, research, education and stratified medicine. The core services offered by AnalyiXagility are applicable to all multidisciplinary teams that want to embrace collaborative data science across all industries. But the additional services that Aridhia has and continues to develop, is what attracted me commercially to the role.
(more…)

Aridhia Wins Genomics England Competition To Help Accelerate The Adoption Of Genomic Medicine

Tuesday, May 6th, 2014

Aridhia, a health and biomedical informatics company, has won a Genomics England-led Small Business Research Initiative (SBRI) competition to accelerate the development of data management and analytical techniques that will help Genomics England transfer genomic science to genomic medicine within the NHS.

Aridhia’s bid focused on the scale and accuracy of the analytics required to deliver genomic medicine as a routine service by enabling the industrialisation of multiple annotation pipelines from different sequence and bio-informatics providers. If healthcare and research organisations are to deliver on the promise of genomic medicine, considerable developments around the integration, clinical validation and curation of large scale clinical and genomic datasets remain.

The objective of the competition was to discover innovative technologies that would address the requirements of Genomics England’s 100k Genome Project and demonstrate that the solution could provide the NHS with meaningful and actionable data based on patients’ genetic material, with the goal of making this data a routine part of clinical decision making.

The Department of Health is investing up to £10m in this competition, which will be managed by Genomics England Limited and which is expected to run in two phases.

The ground-breaking work will be carried out at the Stratified Medicine Scotland Innovation Centre on AnalytiXagility, the recently launched healthcare and research data science platform developed by Aridhia. The consortium of specialists involved in the project and led by Aridhia includes Fios Genomics, EMC and Pivotal.

David Sibbald, CEO of Aridhia, explains: “Clinical interpretation of sequence data can inform likely disease progression, prognosis and can identify potential response to treatment. Ultimately this could lead to improved treatment success rates and reduce unnecessary side effects. One of the key challenges is the availability of industrial-strength annotation pipelines that can be deployed at scale and integrated effectively with a range of other data associated with patient care and treatment.”

Whole genome sequencing is predominantly a research activity today with genomic annotation currently a limited add-on to diagnostics. The Aridhia-led collaboration aims to develop an innovative set of annotation services technologies, based on its existing AnalytiXagility platform, which will address the challenges of delivering clinically relevant reports, as well as the operational challenges in storing and linking genomic and phenotype data.

The ultimate aim is to identify the best way to present this information to clinicians in an easily interpreted format, giving the NHS access to clinically relevant, actionable information which can be used to directly influence patient care.

The project will run in two phases. Firstly the AnalytiXagility platform will be extended to execute instrumented annotation pipelines, yielding valuable data to improve those services. Scalability tests will be run. Secondly, the service will be integrated with NHS systems to demonstrate how genomic data can form part of a patient’s electronic health record in a way that can be used in specialist care. Direct integration of clinical records from the NHS is also expected, along with qualitative measures of user acceptance demonstrated in an NHS setting.

Informatics And A New Business Model Could Unlock Long Term Economic Growth And Sustainability Of Health Sector

Tuesday, December 10th, 2013

In Manchester this week two leading experts in health informatics and big data will urge the UK’s Academic Health Science Networks (AHSNs) to adopt long term commercial thinking in order to improve patient outcomes while delivering economic growth and a sustainable health system.

In 2013, with pressure increasing on the health service to improve treatment and deliver value for money, NHS England created fifteen new Academic Health Science Networks (AHSNs)1, which will focus on innovation to boost outcomes and contribute to economic growth. These organisations bring together education, clinical research, informatics, training and healthcare delivery, and all have wealth creation central to their remit.

In a paper to be presented at the European Connected Health Alliance’s mHealth Ecosystem meeting in Manchester, Dr Cathy Kelly of health and biomedical informatics company Aridhia, and Chris Roche of big data experts EMC, will argue that to create wealth and so deliver growth for the UK’s economy, AHSNs should focus on building an open business model that addresses the long term healthcare market.

The authors counsel that economic growth will be created both from high-value jobs, such as data scientists and application developers, and from the creation of new information services for researchers and clinicians. These services could, and should, extend outside the health service and be offered and consumed by pharmaceutical and clinical research organisations.

The paper recognises the challenges facing AHSNs in their remit as platforms on which the NHS, academia and industry can collaborate to identify innovations and rapidly develop promising solutions to healthcare problems, as well as being tasked with transforming themselves into wealth creation bodies capable of driving economic growth. Prior to the creation of the AHSNs, the NHS was constrained by the need to optimise an existing operating system or adopt a model where only one organisation receives maximum profit.

Co-author and Medical Director of Aridhia, Dr Cathy Kelly, explains: “Early indications are that the UK is leading the charge globally in embracing open business models. If we are to truly have transformational impact on healthcare delivery the new AHSN structure will play a central role in accelerating this work.

“Increasingly clinicians will become responsible not only for the delivery of care, but for patient safety, improved clinical outcomes and patient experience – informatics is key to providing supporting for this.

It becomes evident that to create wealth an AHSN should consider focusing on building an open business model that addresses the long tail market of the healthcare system. Early adopters in this new marketplace are building and investing in an information platform that allow collaboration to take place both at the biomedical informatics level and relationship level.

“What the NHS needs to do to make this a reality is develop effective clinical informatics leadership and trust in the opportunities afforded by safe data sharing.”

Aridhia and EMC are part of a new breed of commercial and clinical partnership for the NHS and are already involved in the development of systems that will support the management of chronic disease. Their work will enable the personalised treatment of tens of millions of people living with chronic diseases including diabetes, cancer, respiratory and cardiovascular disease.

Chris Roche, Chief Technology Officer for EMC EMEA says: “New clinical and patient experiences will be enabled by new data and application fabrics that interact and serve the patient, researcher or clinician in the context of who they are, where they are and what they are doing in the moment. The ability to rapidly collect and analyse massive amounts of clinical, patient, imaging and genomic data and deliver real-time disease management services will enhance service delivery, stratify patient risk and improve clinical outcomes. D oing this in an open source model will facilitate choice and collaboration as the key design principles that underpin the new consumer grade biomedical information platform of future health services.”

The paper, ‘Open Business Models in a long tail market and why executing on a “consumer grade” biomedical informatics platform strategy is key to wealth creation for AHSNs’, will be presented by EMC’s Chris Roche on Thursday 12 December at the European Connected Health Alliance Manchester mHealth Ecosystem meeting. The presentation will be followed by a panel session which will include Dr Andy Judson, Director of Data Science at Aridhia.

The paper introduces business modelling and biomedical informatics concepts that the authors believe the leadership and management of AHSNs will need to embrace if they are to deliver on the wealth creation agenda.

For more information about Academic Health Science Networks (AHSNs) and Academic Health Science Centres (AHSCs): http://www.england.nhs.uk/2013/05/23/acc-health-sci-ntwrk/

Strategic partnership signals new age of stratified medicine

Thursday, May 2nd, 2013

Aridhia and Pivotal™ collaborating on revolutionary solutions for chronic disease management
Edinburgh, UK – May 2nd, 2013 – Health and biomedical informatics company Aridhia today announced a strategic partnership with Pivotal, the company setting the new standard for Enterprise PaaS, to create a new technology platform capable of revolutionising the management of chronic health conditions such as cancer, diabetes and cardiovascular disease.

Developing on the Pivotal One™ platform, the companies will work together to provide the international healthcare, life and biomedical science markets with applications and services that enable the rapid, sophisticated analysis of massive amounts of clinical, patient, imaging and genomic data and provide a comprehensive picture of factors affecting each patient’s treatment and healthcare outcomes.

The collaboration will enable clinicians and researchers to gain fresh insights into correlations between patient, clinical and genomic data and usher in a new age of ‘stratified medicine’, offering improved, personalised treatments tailored to the genetics of individual patients.

As chronic diseases such as cancer, diabetes, respiratory and cardiovascular disease become increasingly prevalent worldwide, Aridhia’s CEO and Chairman, Dr David Sibbald, believes healthcare organisations will rely more on real-time data analysis and disease management services to enhance service delivery, stratify patient risk and improve clinical outcomes.

“Chronic diseases are the leading cause of morbidity and mortality in the world. There is an urgent clinical and economic need to manage those conditions more effectively, which is why we are excited to have the opportunity to join forces with Pivotal. Medicine and biology are rapidly becoming information sciences and this collaboration will not only allow us to enhance our existing biomedical informatics solutions, but will also deliver the advanced informatics services required for the development of stratified medicine.

“An individual’s genetic profile can have a significant impact on the choice and effectiveness of their treatment plan. Our approach will enable healthcare professionals to treat patients with all the necessary information available at the point of care, presenting data in a way that supports safe, effective and patient-centred health care.

“By combining our health and biomedical informatics expertise with Pivotal’s outstanding capability in real-time, high-capacity analytics and scalability, we are a step closer to our goal of becoming a world leader in the detailed analysis of clinical and scientific information required for the personalised treatment pathways of the future,” says Dr Sibbald.

Chris Roche, Chief Technology Officer in Europe, Middle East and Africa at Pivotal, agrees that the new collaboration has the potential to produce improvements in the treatment and outcomes of tens of millions of people living with chronic disease worldwide. Roche says: “Health and biomedical solutions utilising the latest analytical techniques can enable easier identification of the risks of chronic disease and ensure patient management is as effective as possible. With healthcare budgets being squeezed, and chronic disease a growing problem in an ageing population across the world, the application of advanced analytics aligned to clinical practice will become increasingly important. Applied in this way, the right technology has the potential to assist with the proper targeting of resources, and the effective mitigation of the effects of diabetes, cancer, respiratory and cardiovascular disease worldwide.”

Roche continued “Aridhia has successfully built a team of clinicians, life scientists, data scientists and software developers to tackle simultaneously the complexities of disease management within ever-changing healthcare systems. This multidisciplinary combination of clinical and informatics domain expertise is very rare and we’re extremely pleased to be partnering and collaborating within this field.”

With the prohibitive cost of sequencing an individual’s genome continuing to fall rapidly, stratified medicine is widely predicted to be a huge growth area for healthcare providers over the next decade.

Unique collaboration to drive groundbreaking healthcare research through Stratified Medicine Scotland Innovation Centre

Tuesday, April 23rd, 2013

Aridhia, academic, NHS and industrial partners to drive fusion of genomic and patient data to enable faster, more accurate clinical decisions.
Biomedical informatics company Aridhia today announced that it is a lead commercial partner alongside Life Technologies Corporation, a global biotechnology tools company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The SMS-IC is a unique collaboration bringing together expertise from within Scottish industry, academia and the NHS to drive forward a new age of stratified medicine globally, with the aim of offering improved, personalised healthcare treatments, tailored to the genetics of individual patients.

“The Stratified Medicine Scotland Innovation Centre is a globally significant programme to determine the future of healthcare in the 21st century and Aridhia is very proud to be part of it. With the cost of sequencing an individual’s genome continuing to fall rapidly, we need to understand how to find and unlock the associations with clinical and patient data in order to improve diagnosis and to personalise the treatment of disease to the individual. Do this, and we can change the way in which healthcare is delivered forever,” said Dr David Sibbald, CEO and Chairman of Aridhia.

“Aridhia will provide the biomedical informatics platform and expertise required to collect, manage and analyse the vast volume and diversity of data that is needed to realise the potential of stratified medicine, while Life Technologies will deliver the DNA sequencing technology to drive discovery and genetic analysis. Together, the two companies can support the development of detailed patient records integrating genomic and clinical data in order to explore the complex relationships between biological pathways and drug response.”

The Stratified Medicine Scotland Innovation Centre aims to build on recent advancements in biomedical research which have begun to identify why people with the same disease do not behave in the same way, and why treatments are more effective for some people than others.

Current methods of managing illness, with standardised, one-size-fits all trial and error medications and treatment pathways, are not always fit for purpose. Combining and analysing an individual’s detailed genomic data with more traditional patient information will enable a move away from standardised to targeted treatments for groups of patients most likely to benefit.

However, while single gene testing is currently available within the NHS, significant advances in stratified medicine are being hampered by the challenge around the interoperability, analysis and interpretation of the huge amounts of data created about each patient. Aridhia’s sophisticated biomedical informatics technologies will provide the SMS-IC with the platform required to analyse these huge amounts of clinical, patient, imaging and genomic data and provide a comprehensive picture of factors affecting each patient’s treatment and healthcare outcomes.
Sibbald continued: “By combining our expertise with that of our academic, clinical and commercial partners, the SMS-IC will support the creation of new knowledge to inform the delivery of quality healthcare across the world and create economic growth for Scotland.”

The immediate aim of SMS-IC is to prove the principle of stratified clinical trials by linking relevant data to enable precision targeting of subsets of the population for clinical trials, beginning with a series of exemplar projects in 2013.

Technology Partnership Signals New Age Of ‘Genetically Personalised’ Healthcare

Monday, March 18th, 2013

Aridhia and EMC Greenplum collaborating on revolutionary chronic disease management solution
Health informatics company Aridhia today announced a partnership with global IT solutions provider EMC Computer System (UK) Ltd to create a new technology platform capable of revolutionising the treatment and management of chronic health conditions such as cancer, diabetes and cardiovascular disease.

Using the EMC Greenplum big data analytics platform, the companies will work together to provide the international healthcare, life and biomedical science markets with services that enable the sophisticated analysis of vast amounts of clinical, patient, imaging and genomic data and provide a comprehensive picture of factors affecting each patient’s treatment and healthcare outcomes.

By delivering the sophisticated IT infrastructure and applications required for the analysis of huge volumes of complex information, Aridhia and EMC will work to enable healthcare providers and researchers to unlock new insights from clinical data and usher in a new age of ‘stratified medicine’, offering improved, personalised healthcare treatments, tailored to the genetics of individual patients.

As chronic diseases such as cancer, diabetes, respiratory and cardiovascular disease become increasingly prevalent worldwide, Aridhia’s CEO and Chairman, Dr David Sibbald, believes healthcare organisations will rely more on real-time data and disease management services to support comprehensive, systematic and personalised patient care:

“Chronic diseases are the leading cause of morbidity and mortality in the world. There is an urgent need to manage these diseases more effectively, which is why we are excited to have the opportunity to join forces with EMC. This partnership will not only allow us to enhance our existing informatics solutions for chronic diseases, but will also deliver the building blocks required for the advancement of preventative care and the development of stratified medicine.

“A person’s genetic profile can have a massive impact on the effectiveness of their treatment plan. Our technology will enable healthcare professionals, for the first time, to truly treat patients as individuals rather than simply as set a set of symptoms.

“By combining our international clinical faculty’s experience and innovations with EMC’s expertise in big data infrastructure and scalability, we are a step closer to our goal of becoming a world leader in the sophisticated analysis of clinical and scientific information required for the personalised, targeted drugs and treatments of the future,” says Dr Sibbald.

Chris Roche, UKI Regional Director of EMC Greenplum, agrees that the new partnership has the potential to produce improvements in the treatment and outcomes of tens of millions of chronic disease sufferers worldwide by replacing current “inadequate” and “wasteful” management systems that are “not always fit for purpose”.

Roche says: “Once chronic disease has taken hold, big data analytics solutions of this type can allow easier identification of the drivers of the condition, to ensure its management is as effective as possible. Current methods of managing chronic illness, with standardised prescriptions and care plans, are not always fit for purpose; proper use of healthcare informatics can minimise the inadequacies or waste that can result from such misallocation of resources.

“With healthcare budgets being squeezed, and chronic disease a growing problem in an aging population across the world, such real-time disease-management techniques will become increasingly important. Applied in this way, the right technology has the potential to assist with the proper targeting of resources, and the effective mitigation of the effects of diabetes, cancer, respiratory and cardiovascular disease worldwide.”

With the prohibitive cost of sequencing an individual’s genome continuing to fall rapidly, stratified medicine is widely predicted to be a huge growth area for healthcare providers over the next decade.


Sign up for Hot Roof Company Subscribers 2015
* = required field